AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24268614 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Narrative Therapy (CNT) and Cognitive‐Behavioral Therapy (CBT)
Number of subjects: 97
Study 22855730 — intervention group
Group type: EXPERIMENTAL
Intervention: exendin‐(9‐39)
Number of subjects: 9
Study 22855730 — intervention group
Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 9
Study 20421000 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 20
Study 20421000 — intervention group
Group type: COMPARATOR
Intervention: Completion of combination therapy
Number of subjects: 20
Study 17702270 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.5 mg/kg
Number of subjects: 37
Study 17702270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 15153888 — intervention group
Group type: EXPERIMENTAL
Intervention: Petrolatum‐delivering body wash applied with a polyethylene puff and 0.1% triamcinolone acetonide (medium strength corticosteroid)
Number of subjects: 60
Study 15153888 — intervention group
Group type: COMPARATOR
Intervention: Synthetic detergent bar soap applied with a washcloth and 0.05% fluocinonide (strong corticosteroid)
Number of subjects: 60
Study 11799303 — intervention group
Group type: EXPERIMENTAL
Intervention: Iscador Quercus spezial(R) (IQ)
Number of subjects: 48
Study 11799303 — intervention group
Group type: EXPERIMENTAL
Intervention: Iscador Pini(R) (IP)
Number of subjects: 48
Study 11799303 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological saline solution)
Number of subjects: 48
Study 9671836 — intervention group
Group type: EXPERIMENTAL
Intervention: Diatek 9000 Infrared Aural Thermometer
Number of subjects: 137
Study 9671836 — intervention group
Group type: EXPERIMENTAL
Intervention: IVAC 2090 CoreCheck Tympanic Thermometer
Number of subjects: 137
Study 9671836 — intervention group
Group type: COMPARATOR
Intervention: Oral electronic thermometer
Number of subjects: 137
Study 9671836 — intervention group
Group type: COMPARATOR
Intervention: Conventional glass mercury thermometer
Number of subjects: 137
Study 7719091 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal perfusion of compound injection of Salvia Miltiorrhiza before closing the abdominal cavity and Dachengqi decoction orally post-operatively
Number of subjects: 47
Study 7719091 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics intraperitoneally before closing the abdominal cavity
Number of subjects: 47
Study 2680475 — intervention group
Group type: EXPERIMENTAL
Intervention: Five or more cups of coffee daily for 4 weeks
Number of subjects: 54
Study 2680475 — intervention group
Group type: EXPERIMENTAL
Intervention: Five or more cups of decaffeinated coffee daily for 4 weeks
Number of subjects: 54
Study 2680475 — intervention group
Group type: EXPERIMENTAL
Intervention: No coffee for 4 weeks
Number of subjects: 54
Study 59627 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-azacytidine (200-250 mg/m2/day X 5 i.v.)
Number of subjects: 24
Study 59627 — intervention group
Group type: COMPARATOR
Intervention: guanazole (25-30 g/m2/day X 5 continuous i.v. infusion)
Number of subjects: 24
Study 31351345 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly clinic visits
Number of subjects: 31
Study 31351345 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortnightly clinic visits
Number of subjects: 31
Study 31351345 — intervention group
Group type: COMPARATOR
Intervention: Weekly clinic visits
Number of subjects: 31
Study 27927734 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-delivered hearing care intervention (HEARS)
Number of subjects: 15
Study 27927734 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment group (waitlist control)
Number of subjects: 15
Study 27927734 — intervention group
Group type: EXPERIMENTAL
Intervention: HEARS intervention (pooled results)
Number of subjects: 15
Study 25599378 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook Social Support Group
Number of subjects: 63
Study 25599378 — intervention group
Group type: COMPARATOR
Intervention: Standard Walking Intervention
Number of subjects: 63
Study 23548422 — intervention group
Group type: EXPERIMENTAL
Intervention: omega‐3 polyunsaturated fatty acids
Number of subjects: 120
Study 23548422 — intervention group
Group type: COMPARATOR
Intervention: standard treatment of CHF
Number of subjects: 120
Study 21651760 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Term Psychodynamic Psychotherapy (STPP) with 25 individual sessions over 6 months
Number of subjects: 105
Study 21651760 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual without specific training (control condition)
Number of subjects: 105
Study 19349389 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracic surgery (VATS) talc poudrage
Number of subjects: 60
Study 19349389 — intervention group
Group type: COMPARATOR
Intervention: Talc slurry (TS) administered through a chest tube
Number of subjects: 60
Study 19349389 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 16291715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of escitalopram
Number of subjects: 0
Study 16291715 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of escitalopram (single or multiple doses)
Number of subjects: 0
Study 16291715 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of escitalopram
Number of subjects: 0
Study 16291715 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent intake of food with escitalopram
Number of subjects: 0
Study 12173165 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk and resilience workshop
Number of subjects: 50
Study 12173165 — intervention group
Group type: EXPERIMENTAL
Intervention: Health information correspondence course
Number of subjects: 50
Study 10547226 — intervention group
Group type: EXPERIMENTAL
Intervention: CVT-1 at doses of 0, 300, 1500, and 3000 mg/day
Number of subjects: 19
Study 10547226 — intervention group
Group type: COMPARATOR
Intervention: CVT-1 at 1000 mg three times daily for 2 weeks
Number of subjects: 19
Study 7799011 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-drugs-in-1-day chemotherapy
Number of subjects: 172
Study 7799011 — intervention group
Group type: COMPARATOR
Intervention: Lomustine (CCNU), vincristine, and prednisone (control regimen)
Number of subjects: 172
Study 2310659 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine
Number of subjects: 11
Study 2310659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 288486 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate, 300 mg t.i.d.
Number of subjects: 27
Study 288486 — intervention group
Group type: COMPARATOR
Intervention: No lithium
Number of subjects: 27
Study 31585826 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenegermin 20 μg/ml, 6 drops daily for 8 weeks
Number of subjects: 48
Study 31585826 — intervention group
Group type: COMPARATOR
Intervention: Vehicle eye drops, 6 drops daily for 8 weeks
Number of subjects: 48
Study 30680850 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper thoracic spine intervention (passive mobilization)
Number of subjects: 20
Study 30680850 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior shoulder intervention (massage, passive mobilization, and stretching)
Number of subjects: 20
Study 30680850 — intervention group
Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 20
Study 28359513 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 2331
Study 28359513 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2331
Study 25885585 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible belt
Number of subjects: 20
Study 25885585 — intervention group
Group type: COMPARATOR
Intervention: Rigid belt
Number of subjects: 20
Study 25885585 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 22664271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound (TUS)
Number of subjects: 0
Study 22664271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21827933 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation techniques for two months
Number of subjects: 0
Study 21827933 — intervention group
Group type: COMPARATOR
Intervention: Control group (no relaxation techniques)
Number of subjects: 0
Study 19268776 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose doxycycline (50 mg/d)
Number of subjects: 60
Study 19268776 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose doxycycline (100 mg/d)
Number of subjects: 60
Study 19268776 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose doxycycline (300 mg/d)
Number of subjects: 60
Study 19268776 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline treatment
Number of subjects: 60
Study 19268776 — intervention group
Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 60
Study 17339500 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent high-intensity exercise (IHE)
Number of subjects: 9
Study 17339500 — intervention group
Group type: COMPARATOR
Intervention: Continuous moderate-intensity exercise (MOD)
Number of subjects: 9
Study 15081437 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 545
Study 15081437 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonists
Number of subjects: 545
Study 11723438 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 116
Study 11723438 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil alone
Number of subjects: 116
Study 11723438 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil and L-Arginine
Number of subjects: 116
Study 9623550 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol measured by HPLC
Number of subjects: 49
Study 9623550 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol analysed by X‐ray fluorescence
Number of subjects: 49
Study 9623550 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-point clearances (HPLC and X-ray fluorescence)
Number of subjects: 49
Study 9623550 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-sample method for GFR >40 ml/min
Number of subjects: 49
Study 9623550 — intervention group
Group type: EXPERIMENTAL
Intervention: X-ray fluorescence analysis of low concentrations of iohexol
Number of subjects: 49
Study 8146789 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular laser blood irradiation (ILBI) with helium-neon laser, daily procedures
Number of subjects: 150
Study 3292719 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin prophylaxis (single prophylactic dose)
Number of subjects: 360
Study 3292719 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial agents (control group)
Number of subjects: 360
Study 31410598 — intervention group
Group type: EXPERIMENTAL
Intervention: Early specialized palliative care plus standard care
Number of subjects: 297
Study 31410598 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 297
Study 30547766 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of mirtazapine with SNRI or SSRI antidepressants
Number of subjects: 59
Study 30547766 — intervention group
Group type: COMPARATOR
Intervention: SNRI or SSRI therapy alone
Number of subjects: 59
Study 26121894 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC video-laryngoscope
Number of subjects: 90
Study 26121894 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 90
Study 23973689 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-HDL-C values
Number of subjects: 1310440
Study 23973689 — intervention group
Group type: COMPARATOR
Intervention: LDL-C levels <70 mg/dl
Number of subjects: 1310440
Study 20234350 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 16 mg/kg/day
Number of subjects: 18
Study 20234350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 18251643 — intervention group
Group type: EXPERIMENTAL
Intervention: Putty P15 and bioabsorbable collagen wound dressing material
Number of subjects: 24
Study 18251643 — intervention group
Group type: COMPARATOR
Intervention: bioabsorbable collagen wound dressing material only
Number of subjects: 24
Study 15999217 — intervention group
Group type: EXPERIMENTAL
Intervention: Darifenacin 7.5 mg
Number of subjects: 439
Study 15999217 — intervention group
Group type: EXPERIMENTAL
Intervention: Darifenacin 15 mg
Number of subjects: 439
Study 15999217 — intervention group
Group type: EXPERIMENTAL
Intervention: Darifenacin 30 mg
Number of subjects: 439
Study 15999217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study 12442180 — intervention group
Group type: EXPERIMENTAL
Intervention: With tourniquet
Number of subjects: 37
Study 12442180 — intervention group
Group type: COMPARATOR
Intervention: Without tourniquet
Number of subjects: 37
Study 10338170 — intervention group
Group type: COMPARATOR
Intervention: Conventional spinal block (n = 60)
Number of subjects: 120
Study 10338170 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral spinal block (n = 60)
Number of subjects: 120
Study 7795833 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 2382
Study 7795833 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced sodium intake
Number of subjects: 2382
Study 7795833 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of weight loss and reduced sodium intake
Number of subjects: 2382
Study 7795833 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 2382
Study 1781272 — intervention group
Group type: EXPERIMENTAL
Intervention: Active anterior computerized rhinomanometry (C.R.) pre- and post-operatively
Number of subjects: 50
Study 1781272 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for patients with increased basal and residual TR
Number of subjects: 50
Study 1781272 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for patients with increased basal TR but normal residual TR
Number of subjects: 50
Study 1781272 — intervention group
Group type: EXPERIMENTAL
Intervention: Aesthetic treatment for patients with normal total basal resistance
Number of subjects: 50
Study 10252500 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-education program consisting of six educational seminars involving various health professionals.
Number of subjects: 0
Study 10252500 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention).
Number of subjects: 0
Study 10252500 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-education program.
Number of subjects: 0
Study 31148401 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified rice
Number of subjects: 160
Study 31148401 — intervention group
Group type: COMPARATOR
Intervention: Ordinary rice
Number of subjects: 160
Study 31148401 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education (more than six modules)
Number of subjects: 160
Study 28485673 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad audiometer app (Audiogram Mobile) using Apple earbud headphones
Number of subjects: 20
Study 28485673 — intervention group
Group type: COMPARATOR
Intervention: 2‐channel Type 1 audiometer (GSI‐61) using EAR insert earphones
Number of subjects: 20
Study 25580924 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabenazine (TBZ) 25-150 mg/d for 6 weeks
Number of subjects: 10
Study 23574533 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/day) plus nateglinide (PIO arm)
Number of subjects: 16
Study 23574533 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride (2 mg/day) plus placebo (GLI arm)
Number of subjects: 16
Study 21535435 — intervention group
Group type: EXPERIMENTAL
Intervention: SenseWear™ Pro(2) Armband
Number of subjects: 29
Study 21535435 — intervention group
Group type: COMPARATOR
Intervention: Indirect calorimetry
Number of subjects: 29
Study 20191170 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions regarding the use of the ABCD rule
Number of subjects: 80
Study 20191170 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instructions)
Number of subjects: 80
Study 17338998 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron sucrose intravenously 200 mg once per week for 5 weeks
Number of subjects: 0
Study 17338998 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate 200 mg by mouth 3 times per day for 8 weeks
Number of subjects: 0
Study 17338998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15550791 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan low dose (12 microg/kg)
Number of subjects: 31
Study 15550791 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan high dose (24 microg/kg)
Number of subjects: 31
Study 15550791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 11523755 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvements to social competence
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods to prevent further impairment and subsequent disability (POID)
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical or occupational therapy, reconstructive surgery, or temporary socioeconomic assistance
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: ICIDH-2 framework for rehabilitation
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies of methods to improve detection of neuropathy
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials of alternative drugs or regimens for treating neuropathy
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies of POID-monitoring systems
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies of instruments to assess limitations of activities and restrictions on participation
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies of the efficacy of various types of rehabilitation interventions
Number of subjects: 0
Study 11201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies of cost-effectiveness of rehabilitation interventions
Number of subjects: 0
Study 9444707 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypotension (mean arterial pressure, MAP, 50‐64 mmHg)
Number of subjects: 36
Study 9444707 — intervention group
Group type: COMPARATOR
Intervention: Normotension (MAP > or = 65 mmHg)
Number of subjects: 36
Study 9444707 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypotension
Number of subjects: 36
Study 9444707 — intervention group
Group type: COMPARATOR
Intervention: Normotension
Number of subjects: 36
Study 1441872 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% prilocaine (20 ml) for 3-in-1 block
Number of subjects: 852
Study 1441872 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml prilocaine for 3-in-1 block
Number of subjects: 852
Study 1441872 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 ml prilocaine for 3-in-1 block
Number of subjects: 852
Study 1441872 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sciatic block
Number of subjects: 852
Study 3515918 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen, 100 mg twice daily
Number of subjects: 133
Study 3515918 — intervention group
Group type: COMPARATOR
Intervention: Naproxen, 250 mg twice daily
Number of subjects: 133
Study 3515918 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen, 100 mg twice daily (open-label phase)
Number of subjects: 133
Study 30745885 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg once-weekly (n = 23)
Number of subjects: 45
Study 30745885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 22)
Number of subjects: 45
Study 27316586 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based integrated cardiac rehabilitation (HBICR)
Number of subjects: 64
Study 27316586 — intervention group
Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 64
Study 25321620 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitinol partially covered SEMS
Number of subjects: 400
Study 25321620 — intervention group
Group type: COMPARATOR
Intervention: Steel partially covered SEMS
Number of subjects: 400
Study 22669847 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal pegaptanib with laser therapy
Number of subjects: 0
Study 22669847 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab monotherapy
Number of subjects: 0
Study 22669847 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy alone
Number of subjects: 0
Study 22669847 — intervention group
Group type: COMPARATOR
Intervention: Control group for bevacizumab
Number of subjects: 0
Study 19728082 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin high dose (80 mg/day)
Number of subjects: 40
Study 19728082 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin low dose (20 mg/day)
Number of subjects: 40
Study 19728082 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (both doses)
Number of subjects: 40
Study 19728082 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (high grade tumors)
Number of subjects: 40
Study 18515511 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsuction drain
Number of subjects: 69
Study 18515511 — intervention group
Group type: COMPARATOR
Intervention: Suction drain
Number of subjects: 69
Study 16082323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus + Sirolimus
Number of subjects: 361
Study 16082323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus + Mycophenolate Mofetil (MMF)
Number of subjects: 361
Study 11922360 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet on the upper arm
Number of subjects: 50
Study 11922360 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet on the forearm
Number of subjects: 50
Study 10516867 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (5 mg/hour intravenously for the first 24 hours, followed by 120 mg t.i.d. perorally for 6 months)
Number of subjects: 70
Study 10516867 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent to verapamil)
Number of subjects: 70
Study 7628095 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecithin/sphingomyelin (L/S) ratios
Number of subjects: 47